It was a fairly quiet week for the Health Business Blog, with some policy posts and miscellaneous musings.
Posts this week included:
- Are biosimilars ethical? raised the question of how we can expect patients to enroll in clinical trials that have no plausible upside for them
- Skeptical about health screenings? Me, too discussed the phenomenon of hospital sponsoring diagnostic testing vans to scoop up new patients
- Wanted: Entrepreneurial business models for doctors made a plea for alternatives to hospital employment
- Big C leads to the Big B (bankruptcy) confirmed that getting cancer can ruin the financial plans of patients, even those with good health insurance
- I'm not worried about an Obamacare induced fast food shortage called the Wall Street Journal on its alarmist coverage of the impact of mandated health insurance on the low-wage restaurant industry
This coming week will start out with an interview with Harvard Pilgrim's CEO about consumer engagement and price transparency.